Status | Study |
Completed |
Study Name: Treatment of Palmar Plantar Erythrodysesthesia (PPE) With Topical Sildenafil Condition: Hand Foot Syndrome Palmar Plantar Erythro Date: 2010-10-08 Interventions: Drug: sildenafil citrate Subjects will be given 2 types of topical creams, one containing 1% sildenafil |
Completed |
Study Name: Study of 0.1% Uracil Ointment (1UO) Ointment for the Prevention of Hand-Foot Syndrome Condition: Palmar-Plantar Erythrodysesthesia Breast Cancer Date: 2010-04-06 Interventions: Drug: Ointment Twice daily lot |
Completed |
Study Name: F511 Cream in Preventing Palmar-Plantar Erythrodysesthesia in Patients Receiving Doxorubicin Hydrochloride Liposome for Metastatic Breast Cancer Condition: Breast Cancer Palmar-plantar Erythrodysesthesia Date: 2009-10-08 Interventions: Drug: antiperspirant cream F511 |
Completed |
Study Name: Eniluracil Hand Foot Syndrome Condition: Breast Cancer Colon Cancer Date: 2009-01-22 Interventions: Drug: Eniluracil Drug: Capecitabine |
Recruiting |
Study Name: A Randomized Trial to Determine if Vitamin B6 Can Prevent Hand and Foot Syndrome in Cancer Patients Treated With Capecitabine Chemotherapy Condition: Hand and Foot Syndrome Date: 2008-10-06 Interventions: Drug: vitamin b6 vitamin b6 10 |
Active, not recruiting |
Study Name: Nicotine Patches in Reducing Hand-Foot Syndrome in Patients Who Are Receiving Capecitabine For Metastatic Breast Cancer Condition: Breast Cancer Chemotherapeutic Agent Toxicity Date: 2008-09-10 Interventions: Drug: nicotine Nicotine patch applied prior to and concurrently with capecitabine chemotherapy or beginn |
Completed |
Study Name: A Study to Determine the Management of Palmar-plantar Erythrodysesthesia (PPE) in Patients With Metastatic Ovarian or Breast Cancer Treated With Caelyx (Study P05020) Condition: Ovarian Neoplasms Breast Neoplasms Paresthesia Date: 2008-09-03 |
Completed |
Study Name: Caelyx in Ovarian Cancer: Prevention and Treatment of Infusion Reactions and Palmar-plantar Erythrodysesthesia (Study P04085)(COMPLETED) Condition: Ovarian Neoplasms Date: 2008-08-26 Interventions: Drug: Caelyx (Pegylated Lyposomal Doxorubicin) Pegylated Lyposomal Doxorubicin, 50 mg/m2 every 4 weeks f |
Completed |
Study Name: A Study of Prophylactic Treatment for Hand-Foot Syndrome in Patients Treated With Oral Xeloda (Capecitabine). Condition: Breast Cancer Date: 2008-04-16 Interventions: Drug: Corticosteroids As presc |
Completed |
Study Name: Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Capecitabine for Advanced Colorectal Cancer or Breast Cancer Condition: Breast Cancer Colorectal Cancer Palm Date: 2007-11-15 Interventions: Dietary Supplement: pyridoxine hydrochloride |